Given that T2DM is associated with low-grade systemic inflammation, we measured several serum markers of inflammation (TNFα, IL-6, C-reactive protein, growth-arrest specific 6, leptin and adiponectin) to test the anti-inflammatory effects of yeast β-glucan. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.